Annual Drug Patent Expirations for MOZOBIL
Mozobil is a drug marketed by Genzyme and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for MOZOBIL.
This drug has forty-five patent family members in twenty-seven countries.
The generic ingredient in MOZOBIL is plerixafor. Two suppliers are listed for this compound. Additional details are available on the plerixafor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
